S&P 500
(-1.57%) 5 035.69 points
Dow Jones
(-1.49%) 37 816 points
Nasdaq
(-2.04%) 15 658 points
Oil
(-0.95%) $81.15
Gas
(-2.16%) $1.948
Gold
(-0.26%) $2 296.90
Silver
(0.25%) $26.72
Platinum
(-0.36%) $944.80
USD/EUR
(0.13%) $0.938
USD/NOK
(0.27%) $11.13
USD/GBP
(0.16%) $0.802
USD/RUB
(0.00%) $93.45

Realaus laiko atnaujinimai Daito Pharmaceutical [4577.T]

Birža: JPX Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta1 geg. 2024 @ 05:35

-0.91% ¥ 2 502.00

Live Chart Being Loaded With Signals

Commentary (1 geg. 2024 @ 05:35):

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies...

Stats
Šios dienos apimtis 40 400.00
Vidutinė apimtis 61 533.00
Rinkos kapitalizacija 39.14B
EPS ¥0 ( 2024-04-12 )
Kita pelno data ( ¥0 ) 2024-07-11
Last Dividend ¥30.00 ( 2023-05-30 )
Next Dividend ¥0 ( N/A )
P/E 12.04
ATR14 ¥1.923 (0.08%)

Tūris Koreliacija

Ilgas: 0.16 (neutral)
Trumpas: 0.58 (weak)
Signal:(37.362) Neutral

Daito Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Daito Pharmaceutical Koreliacija - Valiuta/Žaliavos

The country flag 0.48
( neutral )
The country flag 0.14
( neutral )
The country flag 0.74
( moderate )
The country flag 0.77
( moderate )
The country flag -0.67
( moderate negative )
The country flag 0.23
( neutral )

Daito Pharmaceutical Finansinės ataskaitos

Annual 2022
Pajamos: ¥45.10B
Bruto pelnas: ¥10.33B (22.91 %)
EPS: ¥227.64
FY 2022
Pajamos: ¥45.10B
Bruto pelnas: ¥10.33B (22.91 %)
EPS: ¥227.64
FY 2022
Pajamos: ¥43.46B
Bruto pelnas: ¥11.46B (26.36 %)
EPS: ¥335.41
FY 2021
Pajamos: ¥48.71B
Bruto pelnas: ¥10.79B (22.16 %)
EPS: ¥311.02

Financial Reports:

No articles found.

Daito Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥30.00
(N/A)
¥0
(N/A)
¥30.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Daito Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.80 - Decrease likely (24.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥4.55 2010-05-27
Last Dividend ¥30.00 2023-05-30
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 24 --
Total Paid Out ¥396.45 --
Avg. Dividend % Per Year 0.00% --
Score 3.49 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 3.80
Div. Directional Score 7.50 --
Next Divdend (Est)
(2024-07-08)
¥0 Estimate 3.54 %
Dividend Stability
0.28 Very Poor
Dividend Score
3.49
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
9067.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7952.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
7184.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
6428.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
5408.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4430.T Ex Dividend Knight 2024-05-30 Annually 0 0.00%
3608.T Ex Dividend Junior 2024-02-28 Annually 0 0.00%
2813.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
1433.T Ex Dividend Junior 2024-01-30 Semi-Annually 0 0.00%
9735.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07261.5008.5510.00[0 - 0.5]
returnOnAssetsTTM0.04241.2008.5910.00[0 - 0.3]
returnOnEquityTTM0.06391.500-0.402-0.602[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.290.8003.532.82[1 - 3]
quickRatioTTM1.0830.8008.336.67[0.8 - 2.5]
cashRatioTTM0.2021.5009.9910.00[0.2 - 2]
debtRatioTTM0.0944-1.5008.43-10.00[0 - 0.6]
interestCoverageTTM182.831.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM346.012.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM346.012.0010.0010.00[0 - 20]
debtEquityRatioTTM0.141-1.5009.44-10.00[0 - 2.5]
grossProfitMarginTTM0.2141.0009.779.77[0.2 - 0.8]
operatingProfitMarginTTM0.09301.000-0.139-0.139[0.1 - 0.6]
cashFlowToDebtRatioTTM0.7441.0006.986.98[0.2 - 2]
assetTurnoverTTM0.5840.8009.447.55[0.5 - 2]
Total Score11.20

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM12.041.0008.890[1 - 100]
returnOnEquityTTM0.06392.50-0.258-0.602[0.1 - 1.5]
freeCashFlowPerShareTTM346.012.0010.0010.00[0 - 30]
dividendYielPercentageTTM2.281.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM346.012.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.4751.500-6.500[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1201.0009.500[0.1 - 0.5]
Total Score3.80

Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.